世界の分子診断市場2025

Market Research Futureが発行した調査報告書(MRF20MY077)
◆英語タイトル:Global Molecular Diagnostics Market Research Report Forecast to 2025
◆商品コード:MRF20MY077
◆発行会社(リサーチ会社):Market Research Future
◆発行日:2019年10月
◆ページ数:130
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥467,250見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥656,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Research Future社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、調査手法、市場動向、市場要因の分析、製品別(試薬&キット、楽器、サービス&ソフトウェア)分析、技術別(ポリメラーゼ連鎖反応(PCR)、等温増幅、ハイブリダイゼーション、シーケンス、マイクロアレイ、その他)分析、用途別(感染症、腫瘍学、遺伝子検査、その他)分析、エンドユーズ別(病院&クリニック、診断検査室、その他)分析、地域別分析、競争状況、企業情報などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・市場概要
・調査手法
・市場動向
・市場要因の分析
・分子診断の世界市場:製品別(試薬&キット、楽器、サービス&ソフトウェア)
・分子診断の世界市場:技術別(ポリメラーゼ連鎖反応(PCR)、等温増幅、ハイブリダイゼーション、シーケンス、マイクロアレイ、その他)
・分子診断の世界市場:用途別(感染症、腫瘍学、遺伝子検査、その他)
・分子診断の世界市場:エンドユーズ別(病院&クリニック、診断検査室、その他)
・分子診断の世界市場:地域別
・競争状況
・企業情報
【レポートの概要】

Molecular Diagnostics Market Research Report: Information by Product (Reagents & Kits, Instruments and Services & Software), by Technique (Polymerase Chain Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray and others), by Application (Infectious Diseases, Oncology, Genetic Tests and others), by End User (Hospitals & Clinics, Diagnostic Laboratories and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Global Forecast till 2025

[Market analysis]
Generally, Molecular diagnostic tests have begun a transformation in the diagnosis and checking of infectious diseases over the past several years. Various molecular diagnostic tests such as microbial phenotypic characteristics, chromatographic profiles, bio typing, and vulnerability assessment are most generally used in laboratories for the exposure and diversity of infectious illnesses. But nucleic acid practices and polymerase chain reaction (PCR) are most usually used to carry out testing for communicable diseases. As delineated, molecular analytic is a anthology of skills used to investigate biological markers in genome and proteome. It improves to diagnose and monitor diseases and helps determine which therapy should be administered to the patient. However, the growing frequency of the infectious virus, increasing awareness regarding molecular diagnostic techniques, and development in molecular diagnostics are the primary factors responsible for market growth during the projection period. PCR-based systems are used to detect the etiologic agents of disease directly from clinical samples without the use of culture media. This system is useful in the quick detection of unculturable or fastidious microorganisms. Other significant advances include the determination of viral load and the direct exposure of genes or gene changes accountable for drug resistance. Increased use of automation and user-friendly molecular diagnostic software makes these knowledges more broadly accessible in the marketplace. As a soaring prevalence of infectious disease is detected, the call for molecular diagnostic scanning is also increasing. Overall there has been a notable increase in the number of new and ongoing molecular diagnostic tests as linked to earlier years. Hence, the demand for molecular diagnostics is projected to grow in the future.

[Market segmentation]
The Global Molecular Diagnostics Market has been segmented into product, technique, application, end user and by region. In June 2019, company QIAGEN and McKesson penetrated a delivery contract for the supply of QIAstat-Dx Syndromic Testing Solution to smaller hospitals and other end users in the US. This augmented the delivery network of QIAGEN and McKesson. Additional company in the report can be provided are Bio-Rad Laboratories Inc., Alere, Inc., Bayer AG, Danaher, Sysmex Corporation. Based on application, the market has been bifurcated into infectious disorders, oncology, genetic tests, and others. In January 2019, Hologic, Inc., accepted the US Food and Drug Administration (FDA) approval for the Aptima Mycoplasma Genitalium Assay, used to detect ordinary sexually communicated diseases (STIs). The Aptima assay offered by Hologic, Inc., has helped to thwart the STIs in the US. By end user, the market has been categorized as hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment settled for a market worth of USD 4.078.09 million in 2018. By product, the market has been segregated into reagents & kits, instruments, and services & software. Based on the technique, the market has been divided into a polymerase chain reaction (PCR), isothermal amplification, hybridization, sequencing, microarray, and others. In May 2019, Clonit launched the Quanty Usutu Kit for the identification and quantification of Usutu virus. With this, the company has finalized its range of Arbovirus molecular scans.

[Regional analysis]
Geographically, Global Molecular Diagnostics Market is split in regions like North & Latin America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. the companies operating in the market are mainly focusing on mergers & purchase, which is likely to support market progress. Asia-Pacific is anticipated to be the sharpest-expanding market owing to emerging nations such as China, India, and South Korea emerging as major purposes for the subcontracting of clinical trials, drug production, and pathology assessment. In addition to this, improving healthcare infrastructure has increased the researches being conducted in the region. Additionally, in Asia-Pacific, China settled for a market share of 21.4% in 2018. The molecular diagnostics market in the Middle East & Africa is projected to witness steady growth during the evaluation period due to a lack of understanding of healthcare amenities. In Addition, the global molecular diagnostics market, based on region, has been apportioned into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global molecular diagnostics market for the duration of the prediction period. This is attributed to the increasing geriatric population and the availability of advanced healthcare amenities in the region. The Europe market for molecular diagnostics is projected to be the second biggest during the projection period. The accessibility of assets for research & development and rising support from the government for the life science sector are anticipated to improve the expansion of the market in this province.

[Major players]
The proposed spectators in the Global Molecular Diagnostics Market are Medical device manufacturers and distributors, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global Molecular Diagnostics Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Molecular Diagnostics Market are companies like Hologic, Inc.; QIAGEN; Becton, Dickinson and Company; Abbott Laboratories; Cepheid; F. Hoffmann-La Roche Ltd Thermo Fisher Scientific; Agilent Technologies and Siemens. The key strategies followed by the players operating in the global molecular diagnostics market were innovation, product development, acquisition, and expansion.

【レポートの目次】

Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Overview
4.2 Drivers
4.2.1 Rising Prevalence of Infectious Diseases
4.2.2 Advancements in Molecular Diagnostic Techniques
4.2.3 Rising Prevalence of Different Types of Cancer
4.3 Restraints
4.3.1 Stringent Regulatory Policies
4.4 Opportunities
4.4.1 Entering Developing Economies
4.5 Technology Trends & Assessment
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Good Laboratory Practices
5.1.3 Molecular Diagnostics Testing
5.1.4 Distribution and Sales
5.1.5 Post-Sales Monitoring
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Molecular Diagnostics Market, By Product
6.1 Overview
6.2 Reagents & Kits
6.3 Instruments
6.4 Services & Software
7 Global Molecular Diagnostics Market, By Technique
7.1 Overview
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Amplification
7.4 Hybridization
7.5 Sequencing
7.6 Microarray
7.7 Others
8 Global Molecular Diagnostics Market, By Application
8.1 Overview
8.2 Infectious Diseases
8.3 Oncology
8.4 Genetic Tests
8.5 Others
9 Global Molecular Diagnostics Market, By End-User
9.1 Overview
9.2 Hospitals & Clinics
9.3 Diagnostic Laboratories
9.4 Others
10 Global Molecular Diagnostics Market, By Region
10.1 Overview
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 UK
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Overview
11.2 Company Share Analysis
11.3 Competitive Benchmarking
11.4 Leading Player in Terms of Number of Developments in the Molecular Diagnostics Market
11.5 Key Development Analysis
11.5.1 Partnership/Strategic Agreement
11.5.2 Acquisition
11.5.3 Product Approval
11.5.4 Product Launch
12 Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 Hologic, Inc.
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategies
12.3 Qiagen
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategies
12.4 Becton, Dickinson, and Company
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 Abbott Laboratories
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 Cepheid
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 Siemens
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 CLONIT srl
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 Thermo Fisher Scientific Inc.
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offering
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
12.1 Agilent Technologies
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategies
12.11 EKF Diagnostics
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products/Services Offered
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategies
12.12 Novartis
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Products/Services Offered
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategies
12.13 Illumina
12.13.1 Company Overview
12.13.2 Financial Overview
12.13.3 Products/Services Offered
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.13.6 Key Strategies
13 Appendix
13.1 References
13.2 Related Reports

List of Tables:

TABLE 1 MARKET SYNOPSIS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR REAGENTS & KITS, BY REGION, 2016–2025 (USD MILLION)
TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INSTRUMENTS, BY REGION, 2016–2025 (USD MILLION)
TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SERVICES & SOFTWARE, BY REGION, 2016–2025 (USD MILLION)
TABLE 7 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2016–2025 (USD MILLION)
TABLE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ISOTHERMAL AMPLIFICATION, BY REGION, 2016–2025 (USD MILLION)
TABLE 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HYBRIDIZATION, BY REGION, 2016–2025 (USD MILLION)
TABLE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SEQUENCING, BY REGION, 2016–2025 (USD MILLION)
TABLE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR MICROARRAY, BY REGION, 2016–2025 (USD MILLION)
TABLE 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016–2025 (USD MILLION)
TABLE 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INFECTIOUS DISEASES, BY REGION, 2016–2025 (USD MILLION)
TABLE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ONCOLOGY, BY REGION, 2016–2025 (USD MILLION)
TABLE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR GENETIC TESTS, BY REGION, 2016–2025 (USD MILLION)
TABLE 18 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016–2025 (USD MILLION)
TABLE 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 20 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2016–2025 (USD MILLION)
TABLE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016–2025 (USD MILLION)
TABLE 22 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016–2025 (USD MILLION)
TABLE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION)
TABLE 24 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION)
TABLE 25 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 26 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 27 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 28 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
TABLE 30 NORTH AMERICA: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%)
TABLE 31 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 32 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 35 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 36 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 37 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 38 US: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 39 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 40 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 41 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 42 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 43 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 44 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 45 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 46 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 47 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION)
TABLE 48 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 49 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 50 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 51 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 52 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
TABLE 53 WESTERN EUROPE: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%)
TABLE 54 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 55 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 56 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 57 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 58 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 59 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 60 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 61 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 62 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 63 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 64 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 65 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 66 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 67 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 68 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 69 UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 70 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 71 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 72 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 73 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 74 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 75 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 76 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 77 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 78 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 79 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 80 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 81 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 82 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 83 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 84 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 85 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 86 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
TABLE 87 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%)
TABLE 88 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 89 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 90 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 91 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 92 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 93 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 94 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 95 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 96 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 97 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 98 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 99 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 100 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 101 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 102 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 103 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 104 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 105 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 106 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 107 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 108 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 109 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 110 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 111 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 114 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 115 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 121 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 122 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 123 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 124 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 125 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION)
TABLE 126 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION)
TABLE 127 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION)
TABLE 128 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION)
TABLE 129 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MOLECULAR DIAGNOSTICS MARKET
TABLE 130 PARTNERSHIP/STRATEGIC AGREEMENT
TABLE 131 ACQUISITION
TABLE 132 MERGER & ACQUISITION
TABLE 133 PRODUCT LAUNCH

【掲載企業】

Hologic, Inc.; QIAGEN; Becton, Dickinson and Company; Abbott Laboratories; Cepheid; F. Hoffmann-La Roche Ltd Thermo Fisher Scientific; Agilent Technologies and Siemens

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の分子診断市場2025(Global Molecular Diagnostics Market Research Report Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆